AUSTIN, Texas -- An Austin medical patient is claiming that a polypropylene mesh, widely used to repair hernias in men of reproductive age, has left him sterile. Thomas Crowson, Jr. and his wife, Andrea, are suing the manufacturer, Davol, Inc., of Cranston, R.I., alleging that the company marketed a defective product and was negligent in failing to warn doctors and patients of the problem.
"We have information that leads us to believe that many, many more inguinal hernia patients, who used this particular mesh product, are sterile because of this mesh," says attorney Brian Keller, who is representing the Crowson family. "We also believe the manufacturer has covered up the problem." Keller is a partner in the Houston law firm, Hicks Thomas & Lilienstern.
An inguinal hernia, or groin hernia, is one of the most common forms of abdominal hernia. It occurs when a part of the intestine pushes through an opening in the abdominal wall down into the inguinal canal. This is the passageway through which the testicles normally descend into the scrotum shortly before birth. According to the American College of Surgeons, approximately 700,000 men in the United States undergo surgical repair for inguinal hernia each year.
The lawsuit alleges that the product, called Bard Mesh, causes scar tissue to develop between the mesh and a part of the body called the spermatic cord. A build-up of too much scar tissue can cause a blockage, leading to sterility.
Hicks Thomas & Lilienstern attorney John Thomas, who is also representing the Crowsons, says the firm is evaluating cases from across the country. "The trend is alarming. There may be many people in this situation who don't even know there is a problem and may never know until they try and have children."
The lawsuit has been filed in the United States District Court for the Western District of Texas, San Antonio Division.
Source: Internet Wire
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.